These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33776879)

  • 1. Neurocognitive Trajectories After 72 Weeks of First-Line Anti-retroviral Therapy in Vietnamese Adults With HIV-HCV Co-infection.
    Paul RH; Shikuma CM; Chau NVV; Ndhlovu LC; Thanh NT; Belden AC; Chow DC; Chew GM; Premeaux TA; Ly VT; McBride JAD; Bolzenius JD; Le T
    Front Neurol; 2021; 12():602263. PubMed ID: 33776879
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.
    Coban H; Robertson K; Smurzynski M; Krishnan S; Wu K; Bosch RJ; Collier AC; Ellis RJ
    AIDS; 2017 Jul; 31(11):1565-1571. PubMed ID: 28471765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
    Ma Q; Vaida F; Wong J; Sanders CA; Kao YT; Croteau D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; Morgello S; Simpson DM; Heaton RK; Grant I; Letendre SL;
    J Neurovirol; 2016 Apr; 22(2):170-8. PubMed ID: 26407716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.
    van Griensven J; Phirum L; Choun K; Thai S; De Weggheleire A; Lynen L
    PLoS One; 2014; 9(2):e88552. PubMed ID: 24533106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM
    PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Hepatitis C Virus Viral Load Among Hepatitis C Virus Mono-Infected and HCV/HIV Co-Infected Individuals in Yunnan Province,China.
    Liu X; He N; Fu Z; Duan S; Gao M; Zhang ZF
    Hepat Mon; 2012 Jul; 12(7):453-9. PubMed ID: 23008726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV.
    Dieterich D; Nelson M; Soriano V; Arastéh K; Guardiola JM; Rockstroh JK; Bhagani S; Laguno M; Tural C; Ingiliz P; Jain MK; Stern JO; Manero M; Vinisko R; Kort J;
    AIDS; 2015 Mar; 29(5):571-81. PubMed ID: 25710287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort.
    Ladep NG; Agaba PA; Agbaji O; Muazu A; Ugoagwu P; Imade G; Cooke G; McCormack S; Taylor-Robinson SD; Idoko J; Kanki P
    World J Gastroenterol; 2013 Mar; 19(10):1602-10. PubMed ID: 23538773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.
    Parsons TD; Tucker KA; Hall CD; Robertson WT; Eron JJ; Fried MW; Robertson KR
    AIDS; 2006 Aug; 20(12):1591-5. PubMed ID: 16868439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of HIV and malaria parasites co-infection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano, Nigeria.
    Jegede FE; Oyeyi TI; Abdulrahman SA; Mbah HA; Badru T; Agbakwuru C; Adedokun O
    PLoS One; 2017; 12(3):e0174233. PubMed ID: 28346490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users.
    Ndombi EM; Budambula V; Webale MK; Musumba FO; Wesongah JO; Mibei E; Ahmed AA; Lihana R; Were T
    Endocr Connect; 2015 Dec; 4(4):223-32. PubMed ID: 26306727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.
    Marcus JL; Leyden WA; Chao CR; Xu L; Quesenberry CP; Tien PC; Klein DB; Towner WJ; Horberg MA; Silverberg MJ
    AIDS Patient Care STDS; 2015 Jul; 29(7):370-8. PubMed ID: 26061798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir.
    Robertson K; Maruff P; Ross LL; Wohl D; Small CB; Edelstein H; Shaefer MS
    J Neurovirol; 2019 Feb; 25(1):22-31. PubMed ID: 30298202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical outcomes between HIV-infected patients with and without HCV co-infection in a resource-limited setting.
    Than NN; Sungkanuparph S; Maek-A-Nantawat W; Kaewkungwal J; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2012 May; 43(3):646-51. PubMed ID: 23077844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.
    Kalichman SC; Washington C; Kegler C; Grebler T; Kalichman MO; Cherry C; Eaton L
    Subst Use Misuse; 2015; 50(12):1536-43. PubMed ID: 26583598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of highly active antiretroviral therapy on liver function in human immunodeficiency virus-infected pediatric patients with or without hepatitis virus co-infection.
    Wu L; Jin C; Bai S; Davies H; Rao H; Liang Y; Wu N
    J Res Med Sci; 2015 Feb; 20(2):127-32. PubMed ID: 25983763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS.
    Vivithanaporn P; Nelles K; DeBlock L; Newman SC; Gill MJ; Power C
    J Neurol Sci; 2012 Jan; 312(1-2):45-51. PubMed ID: 21925684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
    Murata M; Furusyo N; Ogawa E; Mitsumoto F; Hiramine S; Ikezaki H; Takayama K; Shimizu M; Toyoda K; Kainuma M; Hayashi J
    J Infect Chemother; 2014 May; 20(5):320-4. PubMed ID: 24477330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.